Improving patients’ quality of life through early access to advanced medications.
Our knowledge and experience in Emerging Markets set us apart from our competitors. Our own teams located in these areas work with Key Opinion Leaders (KOL) and Patient Advocacy Groups, to understand the unfulfilled needs within a specific disease area, with a focus on rare and orphan diseases.
We want to enable patients to access the products they need, when they need them, even if the products are not yet available in their markets.
We improve access to medicines through;
- Early Access Programmes
- Education through a series of scientific meetings with Key Opinion Leaders
- Local Disease Management and Patient Assistance Programmes through our partnerships with Patient Advocacy Groups.
Masters has a 35-year proven track record of supplying high- quality medicines to under-served markets.
We maintain our reputation and values through ethical and legal sourcing from our select network of reliable and trusted partners, across the developed world. Our customers have access to the widest choice of the latest in advanced or established prescription medicines, and well-known branded pharmaceuticals (or their generic equivalents). We supply innovative specialty medicines that are yet to be locally registered, have been discontinued, or are in short supply.
We operate in a fully licensed and compliant framework that is independently regulated, and quality assured, ensuring the integrity of our supply chain (including cold chain and controlled products) end to end. This framework includes maintaining full batch traceability and Pharmacovigilance. Our customers are guaranteed safe and efficient distribution of medicinal products through our centres in the USA, Central America, South America, Middle East, and Europe.
Most importantly – patient well-being is at the forefront of our minds.
Our partners trust in on our proven capabilities to distribute their specialist drugs, cold-chain medicines, and controlled substances, ensuring product quality and integrity end to end, including the very last mile.
We manage complex logistics and supply chain through our robust WMS and QMS, ensuring that every step of the process is controlled and regulated for safety. Our partners can be assured of the integrity of their products.
Exclusive distribution agreements in the UK, US and Europe:
Partner with Masters and benefit from extensive experience in the supply of specialist medicines, providing a reliable and quality distribution channel with regulatory and demand generation capabilities.
Exclusive distribution of products within Emerging Markets:
Our partners rely on our local knowledge and logistic capabilities to ensure their products are made available to the most remote parts of the world.
Our expertise in Emerging Markets makes us the right choice of partner for managing your innovative products in these complex and challenging areas.
We understand the complexities in bringing medicines to new markets, and over the last 35 years, we have built the knowledge and capabilities to deal with the difficult and often lengthy registration and approval processes. This is where our ‘on the ground’ local expertise and global regulatory capabilities come into their own.
- Extensive knowledge of International competitor landscapes, branded and generic products, and across a number of key therapeutic areas.
- Regional subsidiaries with their own Business Development teams, for local support.
- Insight into market dynamics including; pricing, local reimbursement, and tenders.
- In-house regulatory teams with local knowledge and requirements.
- In-house global marketing and medical information teams, to effectively launch and ensure correct placement.